LS Investment Advisors’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,871
Closed -$32K 1167
2020
Q2
$32K Hold
1,871
﹤0.01% 1276
2020
Q1
$22K Hold
1,871
﹤0.01% 1337
2019
Q4
$52K Sell
1,871
-66
-3% -$1.66K ﹤0.01% 1305
2019
Q3
$44K Buy
1,937
+149
+8% +$3.4K ﹤0.01% 1334
2019
Q2
$45K Sell
1,788
-306
-15% -$8.22K ﹤0.01% 1337
2019
Q1
$57K Sell
2,094
-260
-11% -$8.72K ﹤0.01% 1269
2018
Q4
$78K Sell
2,354
-137
-5% -$5.51K 0.01% 1140
2018
Q3
$116K Sell
2,491
-53
-2% -$2.43K 0.01% 1071
2018
Q2
$110K Sell
2,544
-30
-1% -$1.44K 0.01% 1112
2018
Q1
$143K Sell
2,574
-494
-16% -$27.1K 0.01% 1000
2017
Q4
$164K Sell
3,068
-4,049
-57% -$191K 0.01% 997
2017
Q3
$307K Buy
7,117
+136
+2% +$6.46K 0.02% 754
2017
Q2
$421K Buy
6,981
+940
+16% +$55.7K 0.03% 578
2017
Q1
$419K Buy
6,041
+94
+2% +$6.53K 0.03% 537
2016
Q4
$396K Buy
5,947
+279
+5% +$18.1K 0.03% 499
2016
Q3
$376K Sell
5,668
-716
-11% -$49K 0.03% 483
2016
Q2
$462K Buy
6,384
+2,272
+55% +$156K 0.03% 442
2016
Q1
$266K Sell
4,112
-215
-5% -$14.3K 0.02% 576
2015
Q4
$310K Buy
+4,327
New +$320K 0.02% 534

Other funds holding MD

LS Investment Advisors's MD Position: Q3 2020 in Review

LS Investment Advisors sold out of Pediatrix Medical (MD) in Q3 2020, closing a stake of 1,871 shares — an estimated $32K sold.

LS Investment Advisors first reported a position in MD in Q4 2015 and held it in 19 quarters. The position peaked at $462K in Q2 2016. 207 funds tracked by Wall St. Rank hold MD as of Q3 2020.

  • LS Investment Advisors reported no remaining Pediatrix Medical position as of Q3 2020 after selling out during the quarter.
  • LS Investment Advisors sold 1,871 Pediatrix Medical shares in Q3 2020, an estimated $32K.
  • LS Investment Advisors first reported a position in Pediatrix Medical in Q4 2015 and held it in 19 quarters.
  • LS Investment Advisors's Pediatrix Medical position peaked at $462K in Q2 2016.
  • 207 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2020.

Based on LS Investment Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.